Treatment Pipeline
Track therapies in development for inherited retinal diseases — from early clinical trials through FDA approval. Data sourced from ClinicalTrials.gov and the Foundation Fighting Blindness.
50
Total Therapies
1
FDA Approved
8
Phase 3 / 2/3
9
Modalities
37
Conditions Targeted
Development Pipeline
Showing 50 of 50 therapies
Approved(1 therapy)
Phase 3(7 therapies)
Phase 2/3(1 therapy)
Phase 2(5 therapies)
Phase 1/2(2 therapies)
Phase 1(5 therapies)
Specials Program(1 therapy)
Pilot Phase(1 therapy)
EARLY/Phase 1(3 therapies)
NA(1 therapy)
Phase 1, Phase 2(21 therapies)
Phase 2, Phase 3(2 therapies)
Disclaimer: This pipeline tracker is for informational purposes only. Clinical trial phases and statuses change frequently. Always consult ClinicalTrials.gov for the most current information and speak with your physician before making treatment decisions. Data sourced from the Foundation Fighting Blindness Clinical Trial Pipeline, ClinicalTrials.gov, and company press releases.